Abstract:Objective To evaluate the safety and efficacy of the intravitreal methotrexate treatment in patients with primary vitreoretinal lymphoma (PVRL).Methods Retrospective non comparative interventional ease series.Fourteen patients (26 eyes) with biopsy-proven PVRL were included in the study.All patients received examination of Snellen chart visual acuity,fundus color photography and optical coherence tomography (OCT).Among the 24 eyes with recordable visual acuity,17 eyes has initial visual acuity ≥ 0.1 (0.45± 0.20) and 7 eyes with initial visual acuity ranged from light perception to hand movement.The vitreous opacities and (or) subretinal yellowish white lesions and retinal pigment epithelium uplift were observed in all eyes.All eyes were treated with intravitreal methotrexate (4000 μg/ml,0.1 ml)injections according to a induction-consolidation-maintenance regimen.For 26 treated eyes,each received an average of (11.5±6.3) injections.Twenty eyes had finished the intraocular chemotherapy,while 6 eyes had not.Eight of 20 eyes were clinically confirmed free of tumor cells by diagnostic vitrectomy,12 eyes were still with tumor cell involvement.The follow-up was ranged from 2 to 48 months,the mean time was 18 months.The examination of BCVA,fundus color photography and OCT were performed.No tumor cell was defined as clinical remission.Visual acuity was scored as improved or declined obviously (improved or declined 2 lines) or mild improved or declined (changed within 2 lines).Results Twenty eyes achieved clinical remission after (3.5± 3.6) injections,12 eyes of 20 eyes with tumor cell involvement before chemotherapy achieved clinical remission after (5.8 ± 3.0) injections.The mean visual acuity of seventeen eyes with initial visual acuity 0.1 in induction phase and at the end of treatment were 0.36 ± 0.23 and 0.56±0.20,respectively.Compared with before treatment,the visual acuity was mild declined in induction phase (t=1.541,P＞0.05),but mild improved at the end of treatment (t=2.639,P＜0.05).The visual acuity at the end of treatment in 7 eyes with initial visual acuity ＜0.1 was ranged from no light perception to 0.1.()f 14 patients,2 patients have been fatal because of brain lesions progression at 42 and 48 months after diagnosis of primary central nervous system lymphoma.No ocular recurrence was noted during the follow-up in 20 eyes who finished intraocular chemotherapy.Conclusions PVRL patients can achieve clinical remission after (3.5 ±3.6) injections by intravitreal chemotherapy of methotrexate,and the visual acuity improved mildly.No ocular recurrence was found during follow-up.

Systemic Combined with Intravitreal Methotrexate for Relentless Placoid Chorioretinitis: A Case Report

Extensive Submacular Haemorrhage in Polypoidal Choroidal Vasculopathy Managed by Sequential Gas Displacement and Photodynamic Therapy: a Pilot Study of One‐year Follow Up

Treatment of Idiopathic Orbital Myositis with Frequent Relapses: First Case with Tacrolimus and Review of Literature

The role of Intravitreal Methotrexate as an Adjunct to Local or Systemic Corticosteroids in Vitrectomy for Rhegmatogenous Retinal Detachment and Choroidal Detachment: A Pilot Study

Atypical Acute Syphilitic Posterior Placoid Chorioretinitis

Longitudinal Analysis of Ocular Manifestation and Interleukin during Intravitreal Treatment of Vitreoretinal Lymphoma with Methotrexate

Serial Intravitreal Methotrexate Injections to Combat Recurrent Proliferative Vitreoretinopathy in a Pediatric Patient

INTRAVITREAL METHOTREXATE INJECTION FOR THE TREATMENT AND PREVENTION OF PROLIFERATIVE VITREORETINOPATHY

Simultaneous Intravitreal Steroid and Anti-VEGF Therapy for Monotherapy-Resistant Chronic Wet Age-Related Macular Degeneration

Successful Use of Intravitreal Bevacizumab and Methotrexate in a Case of Neovascularization of the Iris and Pseudohypopyon Secondary to Recurrent Diffuse Large B-Cell Lymphoma

Development of Cytomegalovirus Corneal Endotheliitis During Long-Term Topical Tacrolimus and Steroid Treatment for Chronic Ocular Surface Inflammatory Diseases

Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report

Intravitreal Methotrexate Chemotherapy in the Treatment of 14 Patients with Priamary Vitreoretinal Lymphoma

Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression

Purtscher-like Retinopathy Associated with Systemic Lupus Erythematosus Treated with Rituximab Plus Low-Dose Interleukin-2: A Case Report

Bilateral simultaneous central retinal vein occlusion in hyperviscosity retinopathy treated with systemic immunosuppressive therapy only

Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study

Punctate inner choroiditis and choroidal neovascular membrane formation following vitreoretinal surgery: A case report

Highly suspected primary intraocular lymphoma in a patient with rheumatoid arthritis treated with etanercept: a case report

[Photodynamic therapy for treatment of chronic or recurrent central serous chorioretinopathy].

Sequential spontaneous resolution of acute syphilitic posterior placoid chorioretinitis